Table 3.

Crude and adjusted odds ratios for microalbuminuria (MA; 30–300 mg/24 h): antihypertensive drugs.

	Number of users		OR crude	OR adjusted†
Drug group	No MA	MA	(95% CI)	(95% CI)
β-adrenoceptor blockers	426	110	1.97 (1.58, 2.46)*	1.01 (0.78, 1.30)
α-adrenoceptor blockers	16	9	4.04 (1.78, 9.18)*	1.71 (0.70, 4.21)
Diuretics	286	73	1.90 (1.45, 2.48)*	0.86 (0.63, 1.18)
Thiazide diuretics	186	44	1.73 (1.23, 2.42)*	0.78 (0.53, 1.15)
Potassium sparing diuretics	58	15	1.86 (1.05, 3.30)*	1.01 (0.55, 1.85)
Loop diuretics	53	16	2.18 (1.24, 3.82)*	0.94 (0.50, 1.78)
RAS-inhibitors	266	82	2.33 (1.80, 3.02)*	0.99 (0.73, 1.35)
ACE inhibitors	237	66	2.07 (1.56, 2.75)*	0.90 (0.65, 1.25)
Ang II antagonists	34	19	4.06 (2.30, 7.14)*	1.81 (0.97, 3.35)
Calcium channel blockers	178	83	3.58 (2.73, 4.70)*	1.67 (1.22, 2.28)*
Dihydropyridine CCB	113	55	3.65 (2.62, 5.08)*	1.76 (1.22, 2.54)*
Non-dihydropyridine CCB	68	29	3.12 (2.00, 4.84)*	1.43 (0.87, 2.34)

^*Significant (P < 0.05).

^†Adjusted for age, sex, mean arterial pressure, cholesterol level, smoking, other antihypertensives and use of at least one other cardiovascular drug.